Location: Las Vegas, NV
CIK: 0002106939 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: Apr 17, 2026
Total Value: $141M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SGOV | ISHARES TR | 700,000 | $70.46M | 49.9% | $100.38 | — | 0-3 MNTH TREASRY | 46436E718 |
| XBI | SPDR SERIES TRUST | 284,900 | $36.39M | 25.7% | $127.73 | — | STATE STREET SPD | 78464A870 |
| SERA | SERA PROGNOSTICS INC | 2,396,685 | $4.865M | 3.4% | $2.95 | 0.0% | CLASS A COM | 81749D107 |
| DFTX | DEFINIUM THERAPEUTICS INC | 34,800 | $658K | 0.5% | $16.29 | 0.0% | COM SHS | 24477V105 |
| TYRA | TYRA BIOSCIENCES INC | 16,000 | $613K | 0.4% | $18.37 | +64.7% | COM | 90240B106 |
| ASND | ASCENDIS PHARMA A/S | 2,500 | $572K | 0.4% | $213.24 | — | SPONSORED ADR | 04351P101 |
| PHVS | PHARVARIS N V | 20,000 | $565K | 0.4% | $24.09 | +11.0% | COM | N69605108 |
| CYTK | CYTOKINETICS INC | 8,300 | $547K | 0.4% | $62.21 | +3.6% | COM NEW | 23282W605 |
| RPRX | ROYALTY PHARMA PLC | 11,000 | $528K | 0.4% | $38.13 | +10.9% | SHS CLASS A | G7709Q104 |
| KYMR | KYMERA THERAPEUTICS INC | 6,300 | $525K | 0.4% | $67.53 | +14.9% | COM | 501575104 |
| HALO | HALOZYME THERAPEUTICS INC | 8,026 | $519K | 0.4% | $67.27 | +9.4% | COM | 40637H109 |
| EXEL | EXELIXIS INC | 11,948 | $512K | 0.4% | $41.37 | +5.8% | COM | 30161Q104 |
| IRON | DISC MEDICINE INC | 8,000 | $512K | 0.4% | $74.04 | 0.0% | COM | 254604101 |
| IONS | IONIS PHARMACEUTICALS INC | 6,800 | $511K | 0.4% | $75.30 | +8.6% | COM | 462222100 |
| AGIO | AGIOS PHARMACEUTICALS INC | 15,000 | $507K | 0.4% | $28.04 | 0.0% | COM | 00847X104 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 3,848 | $507K | 0.4% | $144.56 | -7.1% | COM | 64125C109 |
| INCY | INCYTE CORP | 5,300 | $499K | 0.4% | $96.76 | +6.6% | COM | 45337C102 |
| TARS | TARSUS PHARMACEUTICALS INC | 7,000 | $491K | 0.3% | $74.33 | -6.2% | COM | 87650L103 |
| VKTX | VIKING THERAPEUTICS INC | 15,000 | $488K | 0.3% | $35.35 | -11.3% | COM | 92686J106 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,465 | $485K | 0.3% | $433.60 | -18.5% | COM | 02043Q107 |
| PRAX | PRAXIS PRECISION MEDICINES I | 1,500 | $483K | 0.3% | $186.22 | +67.4% | COM NEW | 74006W207 |
| AXSM | AXSOME THERAPEUTICS INC. | 2,845 | $481K | 0.3% | $180.27 | 0.0% | COM | 05464T104 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 15,000 | $480K | 0.3% | $36.39 | -7.3% | ORDINARY SHARES | N62509109 |
| ARDX | ARDELYX INC | 80,000 | $479K | 0.3% | $7.08 | 0.0% | COM | 039697107 |
| IMVT | IMMUNOVANT INC | 19,200 | $477K | 0.3% | $22.30 | +17.8% | COM | 45258J102 |
| ARGX | ARGENX SE | 641 | $468K | 0.3% | $839.05 | — | SPONSORED ADR | 04016X101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 20,000 | $467K | 0.3% | $17.45 | +19.0% | COM | 87164F105 |
| INBX | INHIBRX BIOSCIENCES INC | 6,927 | $466K | 0.3% | $68.88 | +12.8% | COM | 45720N103 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 19,700 | $464K | 0.3% | $25.66 | +4.6% | COM | 03969K108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 22,100 | $463K | 0.3% | $23.36 | 0.0% | COM | 90400D108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 5,000 | $462K | 0.3% | $71.78 | +34.5% | COM | 604749101 |
| COGT | COGENT BIOSCIENCES INC | 12,000 | $462K | 0.3% | $28.11 | +32.9% | COM | 19240Q201 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 28,000 | $461K | 0.3% | $20.66 | 0.0% | COM | 61225M102 |
| IMCR | IMMUNOCORE HLDGS PLC | 15,141 | $457K | 0.3% | $34.49 | — | ADS | 45258D105 |
| CRSP | CRISPR THERAPEUTICS AG | 9,500 | $452K | 0.3% | $59.89 | -10.7% | NAMEN AKT | H17182108 |
| BBIO | BRIDGEBIO PHARMA INC | 6,000 | $446K | 0.3% | $65.64 | +13.5% | COM | 10806X102 |
| NRIX | NURIX THERAPEUTICS INC | 28,700 | $445K | 0.3% | $14.37 | +20.7% | COM | 67080M103 |
| AUPH | AURINIA PHARMACEUTICALS INC | 30,000 | $445K | 0.3% | $14.18 | +4.3% | COM | 05156V102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 19,766 | $440K | 0.3% | $23.90 | +5.5% | COM | 004225108 |
| RAPP | RAPPORT THERAPEUTICS INC | 14,000 | $438K | 0.3% | $27.68 | +0.6% | COM | 75383L102 |
| IMNM | IMMUNOME INC | 20,000 | $437K | 0.3% | $17.55 | +31.5% | COM | 45257U108 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 9,000 | $433K | 0.3% | $40.11 | +7.6% | ORD SHS CL A | G52694109 |
| TGTX | TG THERAPEUTICS INC | 13,000 | $432K | 0.3% | $32.66 | -9.2% | COM | 88322Q108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 5,000 | $420K | 0.3% | $38.77 | +22.7% | COM | 252828108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 13,000 | $412K | 0.3% | $26.34 | -3.5% | COM NEW | 15117B202 |
| PTCT | PTC THERAPEUTICS INC | 6,000 | $409K | 0.3% | $72.67 | +1.4% | COM | 69366J200 |
| VERA | VERA THERAPEUTICS INC | 10,000 | $402K | 0.3% | $35.52 | +26.6% | CL A | 92337R101 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 14,283 | $400K | 0.3% | $32.88 | +8.5% | COM | 413197104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 11,000 | $400K | 0.3% | $44.52 | +10.5% | COM | 22663K107 |
| CMPS | COMPASS PATHWAYS PLC | 71,000 | $393K | 0.3% | $5.53 | — | SPONSORED ADS | 20451W101 |
| STOK | STOKE THERAPEUTICS INC | 12,000 | $391K | 0.3% | $30.06 | +5.9% | COM | 86150R107 |
| KOD | KODIAK SCIENCES INC | 10,000 | $381K | 0.3% | $20.48 | +24.1% | COM | 50015M109 |
| DYN | DYNE THERAPEUTICS INC | 20,000 | $363K | 0.3% | $18.94 | -9.6% | COM | 26818M108 |
| TRVI | TREVI THERAPEUTICS INC | 30,000 | $358K | 0.3% | $10.94 | 0.0% | COM | 89532M101 |
| NTLA | INTELLIA THERAPEUTICS INC | 26,900 | $345K | 0.2% | $12.40 | 0.0% | COM | 45826J105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,000 | $316K | 0.2% | $81.85 | +1.8% | COM | 74366E102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 600 | $314K | 0.2% | $510.76 | -3.6% | COM | 558868105 |
| SUPN | SUPERNUS PHARMACEUTICALS | 6,000 | $310K | 0.2% | $48.62 | +3.9% | COM | 868459108 |
| TNGX | TANGO THERAPEUTICS INC | 14,400 | $301K | 0.2% | $11.91 | 0.0% | COM | 87583X109 |
| ERAS | ERASCA INC | 17,327 | $280K | 0.2% | $10.02 | 0.0% | COM | 29479A108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 7,000 | $274K | 0.2% | $25.60 | 0.0% | COM | 29337E102 |
| SYRE | SPYRE THERAPEUTICS INC | 5,159 | $260K | 0.2% | $26.13 | +32.2% | COM NEW | 00773J202 |
| ZYME | ZYMEWORKS INC | 10,000 | $250K | 0.2% | $21.81 | +7.2% | COM | 98985Y108 |
| XENE | XENON PHARMACEUTICALS INC | 4,200 | $244K | 0.2% | $42.00 | -0.0% | COM | 98420N105 |
| ORKA | ORUKA THERAPEUTICS INC | 4,968 | $244K | 0.2% | $32.45 | 0.0% | COM | 687604108 |
| CELC | CELCUITY INC | 2,000 | $228K | 0.2% | $82.21 | +30.7% | COM | 15102K100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 10,795 | $217K | 0.2% | $15.49 | 0.0% | COM | 483497103 |
| LEGN | LEGEND BIOTECH CORP | 12,000 | $217K | 0.2% | $21.74 | — | SPONSORED ADS | 52490G102 |
| ALKS | ALKERMES PLC | 6,000 | $212K | 0.2% | $29.95 | +8.0% | SHS | G01767105 |
| APGE | APOGEE THERAPEUTICS INC | 2,500 | $210K | 0.1% | $62.99 | +14.7% | COM | 03770N101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 350 | $208K | 0.1% | $465.69 | +3.2% | COM | 91307C102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,500 | $205K | 0.1% | $28.18 | 0.0% | COM | 28036F105 |
| SMMT | SUMMIT THERAPEUTICS INC | 10,223 | $194K | 0.1% | $16.20 | 0.0% | COM | 86627T108 |
| ORIC | ORIC PHARMACEUTICALS INC | 13,000 | $165K | 0.1% | $10.77 | 0.0% | COM | 68622P109 |
| CMPX | COMPASS THERAPEUTICS INC | 30,000 | $159K | 0.1% | $6.00 | 0.0% | COM | 20454B104 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 10,838 | $151K | 0.1% | $13.58 | +3.0% | COM | 03237H101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 10,000 | $149K | 0.1% | $17.79 | +43.1% | COM | 68062P106 |
| EYPT | EYEPOINT INC | 10,000 | $129K | 0.1% | $14.17 | +7.4% | COM NEW | 30233G209 |
| OCUL | OCULAR THERAPEUTIX INC | 15,000 | $127K | 0.1% | $12.15 | -19.1% | COM | 67576A100 |